google-site-verification: googlec7193c3de77668c9.html

A new triple negative breast cancer target: Why HORMAD1 could guide treatment choices

[
A gene that is typically active only in reproductive cells may hold the key to new treatments for triple negative breast cancer, according to new research published in the journal Nature Communications. Scientists from the Breast Cancer Now Toby Robins Research Center at The Institute of Cancer Research, London (ICR) and the Breast Cancer Now Research Unit at King’s College London, have uncovered a new weakness in triple negative breast cancer linked to a gene called HORMAD1 and a way to target it.


Source link

Advertisements
Views: 2

See also  Risk profile tool provides clearer insight on hospitalized COVID-19 patients who benefit most from baricitinib treatment

Check Also

How serotonin may help drive long-term allergic inflammation through overlooked immune cells

[ Schematic of the glycolytic pathway and inhibition with 2-deoxyglucose (2DG). Credit: Allergy (2026). DOI: …

Shared neurodevelopmental spectrum could link ADHD, autism and dyslexia to later outcomes

[ Credit: Unsplash/CC0 Public Domain A paper published in Molecular Psychiatry, led by researchers from …

Preserved testicular tissue produces early germ cells after childhood cancer treatment

[ Credit: Thirdman from Pexels Researchers at Karolinska Institutet have demonstrated that it is possible …

Leave a Reply

Available for Amazon Prime